performance starting from 1 August 2018 after the measurement of fair value of Trans.Ad Group’s identifiable assets was completed. 2019 PERFORMANCE ANALYSIS (YoY) MACO recorded an operating revenue of THB
2Q 2019 CONSOLIDATED P&L SNAPSHOT * The Company restates the financial performance starting from 1 August 2018 after the measurement of fair value of Trans.Ad Group’s identifiable assets was completed
retrospectively. The significant principles are as follows:- Derivative financial instruments are used to manage exposure to foreign exchange and interest rate risks, which are recognized initially at fair value
Administrative expenses 465.22 480.28 (15.06) (3.1) 875.72 791.03 84.69 10.7 (Gain) Loss on fair value adjustment of derivatives 383.14 (107.79) 490.93 455.5 33.29 (2.32) 35.61 1,534.9 Finance costs 429.21 358.72
(excluding fuel cost) 1,950.86 1,218.84 732.02 60.1 Administrative expenses 410.50 340.41 70.09 20.6 Gain (loss) on fair value adjustment of derivatives (349.85) 105.46 (455.31) (431.7) Finance costs 360.44
incurred from the acquisition of GLOW. However, the net profit of the company excluding amortization of the difference between fair value and book value of the net assets of GLOW (Adjusted Net Income
, and the consideration paid, the consideration paid is lower than fair value of net assets transferred. As a result, the Group has gain from business acquisition amounting to Baht 2.2 million, presented
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s